Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preoperative Imaging Diagnostic Evaluation Model Based on Evidence-based Pathological Diagnose Criteria for Renal Cell Carcinoma Tumor Thrombus With Inferior Vena Cava Wall Invasion

NCT05589207 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.

NCT NCT05589207
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05589207 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preoperative Imaging Diagnostic Evaluation Model Based on Evidence-based Pathological Diagnose Criteria for Renal Cell Carcinoma Tumor Thrombus With Inferior Vena Cava Wall Invasion
Lead sponsor
Peking University Third Hospital
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2023
Completion date
January 1, 2027
Enrollment
232 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, renal cell, inferior vena cava interruption, neoplasm invasiveness, tumor thrombus